Maynard Um
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $14 at RBC Capital
-
-
-
-
-
-
-
Perspective Therapeutics, Inc. (CATX) Misses Q3 EPS by 3c
-
-
-
-
-
-
-
Perspective Therapeutics, Inc. (CATX) Reports In-Line Q2 EPS
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $10 at Truist Securities
-
-
-
-
-
-
-
BofA Securities Downgrades Perspective Therapeutics Inc (CATX) to Neutral
-
-
-
-
-
-
-
Truist Securities Starts Perspective Therapeutics Inc (CATX) at Buy
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
-
418,483 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

